Funder
Brody School of Medicine
North Carolina Biotechnology Center
National Science Foundation
Publisher
Springer Science and Business Media LLC
Reference39 articles.
1. Feng W, Zong W, Wang F, Ju S. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Mol Cancer. 2020;19(1):100.
2. Jamal M, Bangash HI, Habiba M, Lei Y, Xie T, Sun J, Wei Z, Hong Z, Shao L, Zhang Q. Immune dysregulation and system pathology in COVID-19. Virulence. 2021;12(1):918–36.
3. World Health Organization. Severe acute respiratory syndrome (SARS). WHO 2022. Available at: https://www.who.int/health-topics/severe-acute-respiratory-syndrome#tab=tab_2. Accessed 20 Dec 2021.
4. Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;1–18.
5. Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y. Precision therapeutic targets for COVID-19. Virol J. 2021;18(1):66.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献